Monte Rosa Therapeutics, Inc. GLUE
- MRT-8102 — Atherosclerotic Cardiovascular Disease Phase 1
- MRT-8102 — Gout Phase 1
- MRT-8102 — Hidradenitis Suppurativa Phase 1
NEK7 (1 companies · 3 programs)
Companies with an active program directed at NEK7.
Companies with an active program directed at NEK7.